Prior Authorization Headaches for Pharma Brand Managers

Prior Authorization Headaches for Pharma Brand Managers 1   About 86% of medical practice leaders reported that prior authorization (PA) requirements have increased over the past year, a 2017 MGMA survey found. Prior authorizations are barriers from health plans which can result in both patient treatment delays as well as changes in preferred therapies or […]

FacebookTwitter

Is Amazon a Threat to Pharma?

Is Amazon a Threat to Pharma? 1   Could the largest online retailer in the world enter the U.S. pharma industry? It may be a smart growth move for a company known for its distribution network. “Amazon may be speaking with mid-sized PBMs now in an effort to get into the pharmacy services space… our specialists […]

FacebookTwitter

Hurricane’s Impact on Puerto Rico and Life Saving Drugs

Hurricane’s Impact on Puerto Rico and Life Saving Drugs 1   The FDA and drugmakers are taking steps to prevent global shortages of critical drugs after Hurricane Maria devastated Puerto Rico, an island that manufactures seven of the top 10 medicines sold worldwide. The FDA commissioner said his agency has about 40 drugs that could […]

FacebookTwitter

Value Based Pricing Gaining Momentum?

Value Based Pricing Gaining Momentum 1 One in four health plans already has at least one outcomes-based contract with a drug maker, and another 30% are in negotiations, according to Avalere Health. The trend is moving toward drug company payments being dependent on drug performance or “value” rather than volume. Pharma companies such as Amgen, […]

FacebookTwitter

HCP Recommendations are Vital for Clinical Trial Recruitment

HCP Recommendations are Vital for Clinical Trial Recruitment 1   Less than 20% of U.S. patients said a healthcare professional (HCP) has talked to them about clinical trial studies, but 81% say it’s likely they would participate in a clinical trial if recommended by an HCP. 77% of patients who did participate in a trial […]

FacebookTwitter
1 2 3 4 12